| Odds Ratio | CI95% | P-value |
Age |
|
| 0.89 |
>55 years | 0.95 | 0.49 - 1.85 | 0.89 |
≤55 years | 1 | - | - |
Gender |
|
| ≤0.001* |
Male | 0.28 | 0.16 - 0.50 | ≤0.001* |
Female | 1 | - | - |
Ethnicity |
|
| 0.00 |
Fons and related tribes | 1 | - | - |
Yoruba and related tribes | 1.46 | 0.65 - 3.26 | 0.356 |
Dendi and related tribes | 8.10 | 1.45 - 45.11 | 0.017* |
Mina and related tribes | 3.66 | 2.19 - 6.10 | ≤0.001* |
Marital status |
|
| 0.00 |
Single | 1 | - | - |
Married | 1.87 | 0.80 - 4.32 | 0.145 |
Widow(er) | 5.52 | 2.19 - 13.91 | ≤0.001* |
Divorced | 5.01 | 1.99 - 12.56 | 0.001* |
Profession |
|
|
|
Civil servant | 1 | - | - |
Craftsman | 2.50 | 1.05 - 5.93 | 0.037* |
Housewife | 3.43 | 1.43 - 8.20 | 0.006* |
Trader | 5.70 | 2.59 - 12.50 | ≤0.001* |
Student/Pupil | 3.37 | 0.75 - 15.05 | 0.11 |
Retired | 5.06 | 0.41 - 62.16 | 0.20 |
Hypertension |
|
| 0.00 |
Yes | 6.88 | 3.53 - 13.40 | ≤0.001* |
No | 1 | - | - |
Clinical stage |
|
| 0.00 |
Stage I | 1 | - |
|
Stage II | 0.66 | 0.30 - 1.44 | 0.29 |
Stage III | 2.43 | 1.23 - 4.81 | 0.01* |
Stage IV | 1.10 | 0.34 - 3.53 | 0.87 |
CD4 count | 0.87 | 0.54 - 1.41 | 0.59 |
Duovir-based therapy | 0.33 | 0.30 - 1.21 | 0.32 |
Screening duration | 1.00 | 1.00 - 1.01 | ≤0.001* |